Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.00636
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 7, 2019
Authors
Publisher
Frontiers Media SA